Editorial content is restricted to original papers on the following areas:<\/p>\r\n\r\n\r\n\r\n
Acta Materia Medica<\/em> publishes research articles, review articles, mini-reviews, commentaries, editorials, short communications, case report articles and study protocols.<\/p>\r\n\r\n\r\n\r\n All research articles, including original research and short communications, must include a graphical abstract.<\/strong><\/p>\r\n\r\n\r\n\r\n The text of research articles should be divided into sections with the headings:<\/p>\r\n\r\n\r\n\r\n The manuscript should have an unstructured English abstract (250 words) representing an accurate summary of the article.\u00a0<\/p>\r\n The prescribed word count for research articles is no more than 5000 words (excluding Abstracts, Acknowledgements, References, figures, and Tables).<\/p>\r\n\r\n\r\n\r\n It is expected that these articles would be written by individuals who have done substantial work on the subject or are considered experts in the field.<\/p>\r\n\r\n\r\n\r\n The manuscript should have an unstructured English abstract (250 words) representing an accurate summary of the article. The section titles will depend upon the topic reviewed.<\/p>\r\n\r\n\r\n\r\n Authors submitting review articles should include a section describing the methods used for locating, selecting, extracting, and analyzing data. These methods should also be summarized in the abstract.<\/p>\r\n\r\n\r\n\r\n Post-publication updates on the subject of review covering the advances in the areas should be sent as a letter to the editor, as and when major developments occur in the field.<\/p>\r\n\r\n\r\n\r\n The prescribed word count is no more than 10,000 words excluding tables, and the Abstract, Acknowledgements, References, figures, and Tables sections.<\/p>\r\n\r\n\r\n\r\n\r\n\r\n The text of Short Communications should be divided into sections with the headings:<\/p>\r\n Abstract (unstructured, less than 250 words)<\/p>\r\n Keywords (3 to 10)<\/p>\r\n Introduction<\/p>\r\n Methods<\/p>\r\n Results<\/p>\r\n Discussion<\/p>\r\n Acknowledgements<\/p>\r\n Conflict of interest<\/p>\r\n References<\/p>\r\n Graphical abstract<\/p>\r\n The prescribed word count for Short Communications is no more than 3,000 words (excluding Abstract, Acknowledgements, References, Figures and Tables). It is recommended that less than 30 references are included.<\/p>\r\n\r\n\r\n\r\n The text of Study Protocols should be divided into sections with the headings:<\/p>\r\n\r\n\r\n\r\n Abstract (unstructured, Objective\/Methods\/Results\/Conclusion, approximately 300 words)<\/p>\r\n\r\n\r\n\r\n Keywords (3 to 10)<\/p>\r\n\r\n\r\n\r\n Introduction<\/p>\r\n\r\n\r\n\r\n Methods<\/p>\r\n\r\n\r\n\r\n Results<\/p>\r\n\r\n\r\n\r\n Discussion<\/p>\r\n\r\n\r\n\r\n Acknowledgements<\/p>\r\n\r\n\r\n\r\n Conflict of interest<\/p>\r\n\r\n\r\n\r\n References<\/p>\r\n\r\n\r\n\r\n The prescribed word count for Study Protocols is no more than 4,000 words (excluding Abstracts, Acknowledgements, References, figures and Tables). Approximately 30 references can be included.<\/p>\r\n\r\n\r\n\r\n Commentaries are commissioned by Editors, and free contributions are not accepted. The manuscript should have an unstructured English abstract (200 words) representing an accurate summary of the article. The section titles will depend upon the topic presented.<\/p>\r\n\r\n\r\n\r\n The prescribed word count for Commentaries is no more than 2,000 words (excluding Abstracts, Acknowledgements, References, figures and Tables). Approximately 20 references can be included.<\/p>\r\n\r\n\r\n\r\n Editorials are written by editorial board members commissioned by Editors, and free contributions are not accepted. The manuscript should have an unstructured English abstract (200 words) representing an accurate summary of the article. The section titles will depend upon the topic presented.<\/p>\r\n\r\n\r\n\r\n The prescribed word count for Editorials is no more than 2,500 words (excluding Abstracts, Acknowledgements, References, figures and Tables). Approximately 20 references can be included.<\/p>\r\n\r\n\r\n\r\n The text of Case report should be divided into sections with the headings:<\/p>\r\n\r\n\r\n\r\n Abstract (unstructured, approximately 150 words)<\/p>\r\n\r\n\r\n\r\n Keywords (3 to 10)<\/p>\r\n\r\n\r\n\r\n Introduction<\/p>\r\n\r\n\r\n\r\n Case presentation<\/p>\r\n\r\n\r\n\r\n Discussion<\/p>\r\n\r\n\r\n\r\n Acknowledgements<\/p>\r\n\r\n\r\n\r\n Conflict of interest<\/p>\r\n\r\n\r\n\r\n References<\/p>\r\n\r\n\r\n\r\n Graphical abstract<\/p>\r\n\r\n\r\n\r\n The prescribed word count for Case report is no more than 1,200 words (excluding Abstracts, Acknowledgements, References, figures and Tables). Approximately 15 references can be included.<\/p>\r\n\r\n\r\n\r\n The manuscript should have an unstructured English abstract (150 words) representing an accurate summary of the article. The section titles will depend upon the topic presented.<\/p>\r\n\r\n\r\n\r\n The prescribed word count for Letter to the Editor is no more than 1,000 words (excluding Abstracts, Acknowledgements, References, figures and Tables). Approximately 15 references can be included.<\/p>\r\n\r\n\r\n\r\n Submissions to Acta Materia Medica<\/em> are made using ScholarOne, the online submission and peer review system. Registration and access are available at https:\/\/mc04.manuscriptcentral.com\/ammed<\/a>.<\/p>\r\n\r\n\r\n\r\n Papers submitted to the Journal should present previously unpublished data or interpretations; they should not be submitted elsewhere while under editorial consideration. Manuscripts should be clear and credible in argument, have a clear hierarchy, use concise headings and have an appropriate mix of text, figures and tables.<\/p>\r\n\r\n\r\n\r\n Presentation<\/em><\/p>\r\n\r\n\r\n\r\n Text should be double-spaced and free of all corrections. Word format is preferred. Figures should be separate from the text; each figure should be presented on a separate A4 sheet.<\/p>\r\n\r\n\r\n\r\n Style<\/em><\/p>\r\n\r\n\r\n\r\n The number of illustrations submitted should not exceed six. Authors should pay particular attention to the clarity and spelling of any lettering on the diagrams, and some reduction in size should be allowed for. All figures must be colour and of a resolution suitable for reproduction.<\/p>\r\n\r\n\r\n\r\n All illustrations should be clearly numbered with the figure number and caption clearly indicated on the bottom of the figure.<\/p>\r\n\r\n\r\n\r\n Accepted file formats include JPG or TIF. Vector files should be CDR format.<\/p>\r\n\r\n\r\n\r\n Table numbers and names should be centred; table footnotes should be included at the bottom of the table; table symbols and units should be clearly designated. Authors are requested to express decimal fractions with full-stops, not commas. Tabulated \u2018raw\u2019 data should be kept to a minimum.<\/p>\r\n\r\n\r\n\r\n Only those references cited in the text, tables and figures should be listed numerically in the bibliography. There should be a minimum of 10 references in each article.<\/p>\r\n\r\n\r\n\r\n Examples of style are:<\/p>\r\n\r\n\r\n\r\n Article within a journal<\/strong> Article within a journal supplement<\/strong> In press article<\/strong> Published abstract<\/strong> Article within conference proceedings<\/strong> Book chapter, or article within a book<\/strong> Whole issue of journal<\/strong> Whole conference proceedings<\/strong> Complete book<\/strong> Monograph or book in a series<\/strong> Book with institutional author<\/strong> PhD thesis<\/strong> Link\/URL<\/strong> Abbreviations<\/strong> Conflict of interests\/competing interests can be defined as factors which could influence the judgment of an author, reviewer or editors, and may be personal, commercial, political, academic, or financial in nature. Put simply, they are interests which, if revealed later, would make a reasonable reader feel misled or deceived.<\/p>\r\n\r\n\r\n\r\n Please see our information pages on our Publication Ethics and Malpractice Statements<\/a>.<\/p>\r\n Acta Materia Medica<\/em> is committed to improving scholarly communications and as part of this commitment, authors may make materials, data and associated protocols available to readers. The preferred way to do this is to publicly deposit the data as noted below. Supplemental material can mean anything from tables to datasets, filesets to presentations, video to audio files. Including supplemental material with your article makes it more discoverable, and Acta Materia Medica<\/em>\u00a0\u00a0will ensure it is effectively linked to within your article.<\/p>\r\n Why include supplemental material with your journal article?<\/strong><\/p>\r\n To support this, if you wish, Acta Materia Medica<\/em>\u00a0\u00a0can include links on your article abstract to the associated data.<\/p>\r\n How do I link my article to its data?<\/strong><\/p>\r\n If you are considering publishing an article with us, and wish to link to supplemental material hosted in a particular data bank, please follow these steps:<\/p>\r\n Are my data files subject to peer\/editorial review?<\/strong><\/p>\r\n No, we don\u2019t expect that the data files will be subject to any special data review or scrutiny.<\/p>\r\n The journal\u00a0requires all authors to follow the correct standards of reporting regarding biomedical research. Please refer to\u00a0EQUATOR<\/a>\u00a0for guidelines for health research and\u00a0MIBBI\u00a0<\/a>\u00a0for guidelines and tools for bioscience reporting. Authors are strongly encouraged to use these guidelines as a checklist when writing their manuscripts.<\/p>\r\n Other available checklists include\u00a0CONSORT\u00a0<\/a>for randomized controlled trials,\u00a0PRISMA<\/a>\u00a0for systematic reviews,\u00a0STROBE<\/a>\u00a0for observational studies,\u00a0MOOSE<\/a>\u00a0\u00a0for meta analyses of observational studies,\u00a0STARD<\/a>\u00a0for diagnostic accuracy studies,\u00a0RATS<\/a>\u00a0\u00a0for qualitative studies, and\u00a0CHEERS<\/a>\u00a0for economic evaluations.<\/p>\r\n Authors of systematic reviews must provide a link in the Methods section that shows all details of the search strategy. Refer to\u00a0Cochrane Reviewers\u2019 Handbook<\/a>\u00a0for examples of the presentation of search strategies.<\/p>\r\n Authors must use standardized gene nomenclature. The\u00a0HUGO Gene Nomenclature Committee<\/a>\u00a0\u00a0details human gene symbols and names. Information on other species can be found at\u00a0https:\/\/www.genenames.org\/help\/faq\/<\/a>; the Human Genome Variation Society provides guidelines on mutation nomenclature.<\/p>\r\n Where appropriate authors should follow CARE<\/a> guidelines for case reports, STREGA<\/a> guidelines for genetic association studies and SRQR<\/a> guidelines for qualitative studies.<\/p>\r\n Authors are expected to comply with current field-specific standards regarding the preparation and recording of data (https:\/\/fairsharing.org\/search?fairsharingRegistry=Standard<\/a>), while also maintaining strict patient confidentiality. In addition, when using unpublished data, authors must make contact with the owners of the data before starting their own research.<\/p>\r\n All human or animal studies should be approved or exempted by the appropriate institutional human and\/or animal subject review committee, or if no formal ethics committee is available, are in accordance with the\u00a0Helsinki Declaration.<\/a>\u00a0This approval or exemption should be stated in the Methods section of the article.<\/p>\r\n When reporting experiments on animals, authors should indicate whether institutional and national standards for the care and use of laboratory animals are followed. Further guidance on animal research ethics is available from the\u00a0International Association of Veterinary Editors\u2019 Consensus Author Guidelines on Animal Ethics and Welfare<\/a> and ARRIVE guidelines https:\/\/www.nc3rs.org.uk\/arrive-guidelines<\/a>.<\/p>\r\n All authors must declare that, where relevant, patient consent has been obtained (or the consent of their parent or guardian in the case of children under 16) and that all reasonable steps have been taken to maintain patient confidentiality, including illustrations, which should be anonymized as far as possible.<\/p>\r\n The journal\u00a0adheres to ICMJE\u2019s\u00a0Clinical Trials Registration Statement<\/a>. All clinical trials published in the journal must be registered in a public trial\u2019s registry at or before the onset of participant enrolment. Manuscripts should include the exact URL and unique identification number for the trial registration at the time of submission. This information will be published in the article and we ask that you include the URL and identification number on the title page of your manuscript.<\/p>\r\n For any clinical trials commencing prior to 2008, retrospective registration will be accepted. A list of recommended registries can be found on the\u00a0ICMJE website<\/a>. Results posted in the same clinical trials registry in which the primary registration resides will not be considered prior publication if they are presented in the form of a brief abstract (500 words or less) or a table.<\/p>\r\n Clinical trials must be reported according to the relevant reporting guidelines, i.e.\u00a0CONSORT<\/a>\u00a0for randomized controlled trials,\u00a0TREND<\/a>\u00a0for non-randomized trials, and\u00a0other specialized guidelines<\/a>\u00a0as appropriate. The intervention should be described according to the requirements of the\u00a0TIDieR checklist and guide<\/a>. Submissions must also include the study protocol as supporting information, which will be published with the manuscript if accepted.<\/p>\r\n Authors of manuscripts describing the results of clinical trials must adhere to the\u00a0CONSORT<\/a>\u00a0reporting guidelines appropriate to their trial design, available on the\u00a0CONSORT Statement web site<\/a>. Any deviation from the trial protocol must be explained in the paper. Authors must explicitly discuss informed consent in their paper, and we reserve the right to ask for a copy of the patient consent form.<\/p>\r\n\r\n
\r\n
\r\n
\r\n
\r\n
\r\n
\r\n
\r\n
\r\n
Online Article Submission<\/strong><\/h2>\r\n\r\n\r\n\r\n
Text<\/strong><\/h5>\r\n\r\n\r\n\r\n
\r\n
Illustrations and Tables<\/strong><\/h2>\r\n\r\n\r\n\r\n
References<\/strong><\/h2>\r\n\r\n\r\n\r\n
Surname A, Surname B, Surname C:\u00a0Article Title.<\/strong>\u00a0Acta Materia Medica<\/em>\u00a02021, 13:266-267.<\/p>\r\n\r\n\r\n\r\n
Surname A, Surname B, Surname C:\u00a0Article Title.\u00a0<\/strong>Acta Materia Medica\u00a0<\/em>2021, 43(Suppl 3):149-170.<\/p>\r\n\r\n\r\n\r\n
Surname A, Surname B, Surname C:\u00a0Article Title.<\/strong>\u00a0Acta Materia Medica<\/em>\u00a02021, in press.<\/p>\r\n\r\n\r\n\r\n
Surname A, Surname BC, Surname C:\u00a0Article Title [abstract].<\/strong>\u00a0Acta Materia Medica<\/em>\u00a02021, 42:s250.<\/p>\r\n\r\n\r\n\r\n
Surname AB, Surname B:\u00a0Article Title.<\/strong>\u00a0In Proceedings of the First National Conference on Acta Materia Medica:<\/em>\u00a027-30 June 2020; New York. Edited by Surname AB. Publisher Location: Publisher Name; 2021:16-27.<\/p>\r\n\r\n\r\n\r\n
Surname A:\u00a0Article Title.<\/strong>\u00a0In Acta Materia Medica.<\/em>\u00a0Volume 1. 2nd edition. Edited by Surname AB. Publisher Location: Publisher Name; 2019:53-76.<\/p>\r\n\r\n\r\n\r\n
Surname A, Surname BC (Eds):\u00a0Article Title.\u00a0<\/strong>In\u00a0Acta Materia Medica<\/em>\u00a02018, 10:1-72.<\/p>\r\n\r\n\r\n\r\n
Surname A (Ed):\u00a0Proceedings of the First National Conference on Acta Materia Medica:\u00a0<\/em>27-30 June 2020; Publisher Location: Publisher Name; 2021.<\/p>\r\n\r\n\r\n\r\n
Surname A:\u00a0Book Title.<\/em>\u00a0Publisher Location: Publisher Name; 2020.<\/p>\r\n\r\n\r\n\r\n
Surname AB, Surname B:\u00a0Chapter Title.\u00a0<\/strong>In Book Title.<\/em>\u00a0Edited by Surname AB. Publisher Location: Publisher Name; 2015:54-56. [Surname A (Series Editor): Series Title, vol 1.]\r\n\r\n\r\n\r\n
Advisory Committee on Acta Materia Medica<\/em>:\u00a0Annual Report<\/em>. Publisher Location; 2019.<\/p>\r\n\r\n\r\n\r\n
Surname A:\u00a0Thesis Title.<\/strong>\u00a0PhD thesis.\u00a0<\/em>University Name, University Department; 2015.<\/p>\r\n\r\n\r\n\r\n
Tumor Biology Database\u00a0<\/strong>[http:\/\/tumor.informatics.jax.org\/cancer_links.html]\u00a0Accessed on date XX<\/p>\r\n\r\n\r\n\r\n
Terminology, quantities, units of measurement and symbols should all adopt the international standard and should be consistently used throughout the manuscript.<\/p>\r\n\r\n\r\n\r\nCompeting Interests<\/strong><\/h2>\r\n
Ethics in publishing<\/strong><\/h2>\r\n
Data and Materials Sharing<\/strong><\/h2>\r\n
\r\n
\r\n
Standards of Reporting<\/strong><\/h2>\r\n
Human and Animal Testing<\/strong><\/h2>\r\n
Patient Consent<\/strong><\/h2>\r\n
Clinical Trials Registration<\/strong><\/h2>\r\n
Registration of Systematic Reviews<\/strong><\/h2>\r\n